OBJECTIVES AND DESIGN: The aim of our study was to simulate in rats all aspects and techniques used in our new clinical program of cryopreserved alloarterial transplantation and investigate the influence of two immunosuppressive protocols with tacrolimus on acute rejection of these allografts. MATERIALS AND METHODS: Cryopreserved abdominal aortic grafts were transplanted between Brown-Norway and Lewis rats. Tacrolimus (0.2 mg/kg daily) was administered from day 1 to day 30 (TAC1) or from day 7 to day 30 (TAC7), respectively. No immunosuppressed isogeneic (ISO) and allogeneic (ALO) rats combination served as control. Aortal wall infiltration by immunocompetent cells (MHC II+ cells of recipient origin) was studied on day 30 after transplantation. Flow cytometry was used for the analysis of day 30 sera for the presence of donor specific anti-MHC class I and II antibodies. RESULTS: The aortal allografts in both immunosuppressed groups showed regular morphology of aortal wall with no depositions of immunoglobulin G on day 30. The adventitial infiltration of non-immunosuppressed aortal allografts by MHC class II positive cells of recipient origin was significantly higher (ALO 20.7±6.7 cells, P<0.001) compared to both immunosuppressed groups (TAC1 5.9±5.5 cells, TAC7 6.1±5.1 cells). Day 30 sera from the allogeneic non-immunosuppressed animals decreased significantly the binding of fluorescence-labelled MHC class I (46.9±19.4%) and class II (65.8±11.9%) antibody to donors spleen cells compared with day 30 sera from both immunosuppressed groups (TAC1, anti-MHC class I 102.4±4.2%, p < 0.001, anti-MHC class II 102.6±6.0%), (TAC7, anti-MHC class I 79.9±3.3%, p < 0.001, anti-MHC class II 80.9±2.7%). CONCLUSION: Both immunosuppressed protocols with tacrolimus (administration from day 1 or from day 7 following transplantation) were able to suppress acute cell- and antibody-mediated rejection of cryopreserved abdominal aortic allografts processed in accordance with our new standardized clinical protocol.

2nd Department of Surgery Department of Cardiovascular Surgery 1st Faculty of Medicine Charles University Prague and General University Hospital Prague Czech Republic

Department of Cardio Vascular Surgery Hospital Hietzing and Karl Landsteiner Institute for Cardio Vascular Research Vienna Austria

Department of Surgery Campus Charité Mitte and Campus Virchow Klinikum Charité Universitätsmedizin Berlin Berlin Germany

Institute of Physiology 1st Faculty of Medicine Charles University Prague

Technology Centre of the Academy of Sciences of the Czech Republic Prague Czech Republic

Tissue Bank Faculty Hospital Hradec Kralove Charles University Faculty of Medicine in Hradec Kralove Hradec Kralove Czech Republic

Zobrazit více v PubMed

Kieffer E, Gomes D, Chiche L, Fleron MH, Koskas F, Bahnini A. Allograft replacement for infrarenal aortic graft infection: early and late results in 179 patients. J Vasc Surg. 2004;39(5):1009–17. 10.1016/j.jvs.2003.12.040 PubMed DOI

Pupka A, Skora J, Janczak D, Plonek T, Marczak J, Szydelko T. In Situ Revascularisation with Silver-coated Polyester Prostheses and Arterial Homografts in Patients with Aortic Graft Infection—A Prospective, Comparative, Single-centre Study. Eur J Vasc Endovasc. 2011;41(1):61–7. PubMed

Bahnini A, Ruotolo C, Koskas F, Kieffer E (1991) In situ fresh allograft replacement of an infected aortic prosthetic graft: eighteen months' follow-up. J Vasc Surg 14: 98–102. PubMed

Matia I, Adamec M, Janousek L, Lipar K, Marada T, Klein D, et al. [Clinical experience with cold-preservation of venous and arterial allografts. long-term outcomes]. Rozhl Chir. 2010;89(1):45–54. PubMed

Sebesta P, Stadler P, Sedivy P, Zdrahal P, El Samman K, Jindrak V, et al. [Radical operation of infected aortofemoral prosthesis using fresh arterial allograft: our mid-term experience]. Rozhl Chir. 2011;90(1):4–13. PubMed

Fellmer P, Matia I, Tautenhahn H-M, Jonas S (2011) [Effect of legal regulations on the use of fresh arterial homografts. Problems in clinical practice]. Gefässchirurgie 16: 403–406.

Špaček M., Měřička P., Janoušek L. et al. Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic. Cell Tissue Bank (2018). 10.1007/s10561-018-9691-4 PubMed DOI

Mirelli M, Stella A, Faggioli GL, Scolari MP, Iannelli S, Freyrie A, et al. Immune response following fresh arterial homograft replacement for aortoiliac graft infection. Eur J Vasc Endovasc Surg. 1999;18(5):424–9. 10.1053/ejvs.1999.0936 PubMed DOI

Konrad H et al. Strong humoral anti-HLA Immune Response Upon Arbitrarily Chosen Allogeneic Arterial Vessel Grafts. J Clin Cell Immunol 2017, 8:525

Matia I, Adamec M, Varga M, Janousek L, Lipar K, Viklicky O. Aortoiliac reconstruction with allograft and kidney transplantation as a one-stage procedure: long term results. Eur J Vasc Endovasc Surg. 2008;35(3):353–7. 10.1016/j.ejvs.2007.09.022 PubMed DOI

da Gama AD, Sarmento C, Vieira T, do Carmo GX. The use of arterial allografts for vascular reconstruction in patients receiving immunosuppression for organ transplantation. J Vasc Surg. 1994;20(2):271–8. PubMed

Sebesta P, Stadler P, Sedivy P, Bartik K. The seven-year' secondary patency of a fresh arterial allograft in the femorocrural position in a heart transplant recipient. Annals of vascular surgery. 2010;24(7):953 e7–e10. PubMed

Matia I, Lodererova A, Adamec M. Delayed administration of FK 506 is sufficient to suppress acute rejection changes after aortal transplantation in rats. Transpl Int. 2007;20(4):371–80. 10.1111/j.1432-2277.2006.00446.x PubMed DOI

Matia I, Fellmer P, Splith K, Varga M, Adamec M, et al. (2014) Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. Ann Transplant 19: 225–232. 10.12659/AOT.889870 PubMed DOI

Měřička P, Špatenka J, Navrátil P. Organization and surgical technique of the tissue harvest in multi-organ harvests In: Baláž P, Janek J, Adamec M (eds.). Organ harvest for transplantation. Karolinum: Prague: 2011: 240–251 [In Czech].

Měřička P., Straková H., Štěrba L., Schustr P., Vinš M.: Cryobank of the Tissue Establishment University Hospital Hradec Králové–Design and 10 year Experience of Operation, The thirteen Cryogenics 2014, IIR International Conference Proceedings, Icaris, Ltd. Prague, 2014, p. 177–182.

van Herck H, Baumans V, Brandt CJ, Hesp AP, Sturkenboom JH, van Lith HA, van Tintelen G, Beynen AC. Orbital sinus blood sampling in rats as performed by different animal technicians: the influence of technique and expertise. Lab Anim. 1998. October;32(4):377–86. 10.1258/002367798780599794 PubMed DOI

Azuma N, Sasajima T, Kubo Y (1999) Immunosuppression with FK506 in rat arterial allografts: fate of allogeneic endothelial cells. J Vasc Surg 29: 694–702. PubMed

Vickery CM, McCombs HL, Warren R (1965) Experimental Small-Artery Grafts in Dogs Treated with Immunosuppressive Drugs. N Engl J Med 272: 325–331. 10.1056/NEJM196502182720701 PubMed DOI

Todd IA, Boctor ZN (1966) Experimental homotransplantation of arteries. Transplantation 4: 123–130. PubMed

Williams GM, ter Haar A, Krajewski C, Parks LC, Roth J (1975) Rejection and repair of endothelium in major vessel transplants. Surgery 78: 694–706. PubMed

Schmitz-Rixen T, Megerman J, Colvin RB, Williams AM, Abbott WM (1988) Immunosuppressive treatment of aortic allografts. J Vasc Surg 7: 82–92. PubMed

Gregory CR, Huie P, Billingham ME, Morris RE (1993) Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation 55: 1409–1418. PubMed

Lemstrom K, Bruning J, Koskinen P, Bruggeman C, Lautenschlager I, et al. (1994) Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats. Transplant Proc 26: 1727–1728. PubMed

Hullett DA, Geraghty JG, Stoltenberg RL, Sollinger HW (1996) The impact of acute rejection on the development of intimal hyperplasia associated with chronic rejection. Transplantation 62: 1842–1846. PubMed

Lacha J, Rossmann P, Lodererova A, Havliekova J, Vitko S (2000) LF 08–0299 in the prophylaxis and treatment of chronic rejection in a rat aortic allograft model. Transpl Int 13 Suppl 1: S565–567. PubMed

Nikolova Z, Hof A, Rudin M, Baumlin Y, Kraus G, et al. (2000) Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Transplantation 69: 2525–2530. PubMed

Ouyang J, Xu D, Zhang X, Qi S, Ma A, et al. (2005) Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections. Transplantation 79: 1386–1392. PubMed

Eckl S et al. Combination of clopidogrel and everolimus dramatically reduced the development of transplant arteriosclerosis in murine aortic allografts. Transpl Int 23 (2010) 959–966. 10.1111/j.1432-2277.2010.01072.x PubMed DOI

Ch Heim. et al.: Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allografts. EJCTS 47(2015) 180–187 PubMed

Harlander-Locke MP, Harmon LK, Lawrence PF, Oderich GS, McCready RA, et al. (2014) The use of cryopreserved aortoiliac allograft for aortic reconstruction in the United States. J Vasc Surg 59: 669–67417 10.1016/j.jvs.2013.09.009 PubMed DOI

Spunda R. et al. Cold-stored arterial allografts for in situ reconstruction of infected prosthetic grafts. Review of immunosuppressive protocols used in clinical practice, Eur Surg (2016) 48 (Suppl2):S166–S168

Freguin-Bouilland C, Godin M, Bellien J, Richard V, Remy-Jouet I, et al. (2011) Protective effect of mycophenolate mofetil on endothelial function in an aortic allograft model. Transplantation 91: 35–41 10.1097/TP.0b013e3181fe12d6 PubMed DOI

Tepperman E, Ramzy D, Prodger J, Sheshgiri R, Badiwala M, et al. (2010) Surgical biology for the clinician: vascular effects of immunosuppression. Can J Surg 53: 57–63 PubMed PMC

Khanna AK, Hosenpud JS, Plummer MS, Hosenpud JD, et al. Analysis of transforming growth factor-beta and profibrogenic molecules in a rat cardiac allograft model treated with cyclosporine. Transplantation 2002; 73: 1543 PubMed

Mennander A, Paavonen T, Hayry P. Cyclosporineinduced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection. Transplant Proc 1992; 24: 341–45 PubMed

Goto T. et al. FK 506:historical perspectives. Transplant Proc.1991,23:2713–2717 PubMed

Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J (2002) A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 73: 775–782. PubMed

Kiji T. et al.: Enhancement of cell viability in cryopreserved rat vascular grafts by administration of regenerating gene (REG) inducers. J Vasc Res, 2003. Mar-Apr;40(2):132–9. 10.1159/000070710 PubMed DOI

Adamec M, Matia I, Janousek L, et al. Renal transplantation in patients with abdominal aortic aneurysm—a new surgical approach. Transpl Int 2004; 17: 647 PubMed

Takeda Y. et al. Mechanism of FK506-Induced Hypertension in the rat, Hypertension. 1999;33:130–136. PubMed

Nalesnik et al. Toxicology of FK-506 in the Lewis rat. Transplant proc. 1987, 19 (5 Suppl 6):89–92. PubMed PMC

Murase N and Todo S and Lee PH and Lai HS and Chapman F and Nalesnik MA and Makowka L and Starzl TE (1987) Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc, 19 (5 Supp). 71–75. ISSN 0041-1345 PubMed PMC

Splith et al. Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats. PLoS One. 2014. March 11;9(3):e91212 10.1371/journal.pone.0091212 eCollection 2014 Plos one PubMed DOI PMC

Viability of Human Arterial Grafts Monitored by Comet Assay

Cell Viability Assessment Using Fluorescence Vital Dyes and Confocal Microscopy in Evaluating Freezing and Thawing Protocols Used in Cryopreservation of Allogeneic Venous Grafts

Characterization and in vitro Analysis of Probiotic-Derived Peptides Against Multi Drug Resistance Bacterial Infections

A Novel Ruthenium Based Coordination Compound Against Pathogenic Bacteria

Influence of the new standardized clinical cryopreservation/slow thawing protocol on immunogenicity of arterial allografts in rats